GlobeNewswire 2022-01-31 XORTX Provides Corporate Update
GlobeNewswire 2022-01-28 Sorrento Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly Neutralize...
GlobeNewswire 2022-01-24 Sorrento Receives Purchase Order for 10 Million Covistix Tests From Its Subsidiary Sorrento Mexico f...
GlobeNewswire 2022-01-21 Sorrento Therapeutics Announces Covishield (Sti-9167), a Broad-Spectrum Neutralizing Antibody, Poten...
GlobeNewswire 2022-01-19 Sorrento Announces That Sorrento Mexico Has Sold Out of One Million COVISTIX Tests Last Week in Mexi...
GlobeNewswire 2022-01-19 Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievem...
GlobeNewswire 2022-01-18 Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC i...
GlobeNewswire 2022-01-13 Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government
GlobeNewswire 2022-01-07 Sorrento Therapeutics Announces the Unexpected Death of its Chief Financial Officer
GlobeNewswire 2022-01-07 Dr. Henry Ji to Present at HC Wainwright BIOCONNECT Virtual Conference (January 10th – 13th)
GlobeNewswire 2021-12-27 Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant
GlobeNewswire 2021-12-27 Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexi...
GlobeNewswire 2021-12-20 Sorrento Therapeutics Announces FDA Clearance of Its IND Application of Next Generation oHSV Oncolyt...
GlobeNewswire 2021-12-09 Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Posit...
GlobeNewswire 2021-12-07 Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment of Pain Due t...
GlobeNewswire 2021-12-07 Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Patho...
GlobeNewswire 2021-12-06 Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
GlobeNewswire 2021-12-06 Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Corp I (NASDAQ:...
GlobeNewswire 2021-12-05 Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for P...
GlobeNewswire 2021-11-30 Dr. Henry Ji to Participate in the CEO Fireside Chat Evercore ISI 4th Annual HealthCONx Conference
GlobeNewswire 2021-11-29 Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – A Franchise Oral Therapeutic for Ca...
GlobeNewswire 2021-11-29 Journey Medical Corporation Introduces Expanded Board of Directors
GlobeNewswire 2021-11-22 Sorrento Therapeutics Mexico Executes Contract for Sale of 5 Million COVI-STIX Tests for Mexico Mark...
GlobeNewswire 2021-11-12 Sorrento Therapeutics Mexico to Partner with the World Boxing Council for the Screening of COVID-19 ...
GlobeNewswire 2021-11-12 Sorrento Announces Publication of Significant Positive Pivotal Trial Results of Abivertinib for the ...